Immunic, Inc.

Leadership moves, last update 2 months ago

Pharma biotech · Headquarters New York, United States

Everything we hold on Immunic, Inc., newest first. Every line links to the filing or report it came from.

1. 2026-06-29
   Headcount Not Stated Leadership moves

   Immunic, Inc. 8-K filing (Item 5.02): officer or director change

   Immunic, Inc. has amended its equity incentive plan, increasing the number of shares available for issuance. The announcement does not disclose any immediate changes to hiring or workforce.

   New York, United States · Official Filing · SEC EDGAR

2. 2026-04-28
   Headcount Not Stated Leadership moves

   Immunic, Inc. Appoints Michael A. Panzara as Chief Medical Officer

   Immunic appoints a new Chief Medical Officer in New York. The announcement does not disclose any changes to headcount.

   New York, United States · Official Filing · SEC EDGAR

3. 2026-03-31
   Headcount Not Stated Leadership moves

   IMMUNIC, INC. 8-K filing (Item 5.02): officer or director change

   Immunic adds a new board member in New York, with no immediate change to executive roles disclosed.

   New York, United States · Official Filing · SEC EDGAR

4. 2026-03-04
   Headcount Not Stated Growing and expanding

   IMMUNIC, INC. raised $200M in a private placement

   IMMUNIC, INC. reported a $200M private placement to the SEC on 2026-03-04, listing an address in New York, NY. The filing records the money only; it names no roles and no hiring plan.

   New York, United States · $200M raised · Official Filing · SEC EDGAR (Form D)

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker